Upon viral infection, antigen-specific CD8 + cytotoxic T cells (CTLs) arise and contribute to the elimination of infected cells to prevent the spread of pathogens. Therefore, the frequency of antigen-specific CTLs is indicative of the strength of the T cell response against a specific antigen. Such analysis is important in basic immunology, vaccine development, cancer immunobiology and the adaptive immunology. In the vaccine field, the CTL response directed against components of a viral vector co-determines how effective the generation of antigen-specific cells against the antigen of interest (i.e., transgene) is. Antigen-specific CTLs can either be detected by stimulation with specific peptides followed by intracellular cytokine staining or by the direct staining of antigen-specific T cell receptors (TCRs) and analysis by flow cytometry. The first method is rather time-consuming since it requires sacrificing of animals to isolate cells from organs. Also, it requires isolation of blood from small animals which is difficult to perform. The latter method is rather fast, can be easily done with small amounts of blood and is not dependent on specific effector functions, such as cytolytic activity. MHC tetramers are an ideal tool to detect antigen-specific TCRs.
Introduction
The aim of this method is to assess the frequency of cytotoxic T lymphocyte (CTL) responses to (multiple) antigens in the mouse by flow cytometric analysis without the need for time-consuming peptide stimulation. This method analyses the phenotype and antigen specificity of CTL subsets, in a single staining. We optimized the Major Histocompatibility Complex I (MHC I) tetramer staining protocol to analyze efficacy of new vaccine approaches, such as VSV-GP, a new variant of the vesicular stomatitis virus (VSV), where the glycoprotein G of VSV has been replaced by the glycoprotein GP of the lymphocytic choriomeningitis virus (LCMV) 1, 2 . In addition to the humoral response, an important readout of the effectivity of a vaccine is the induction of a CTL response against one or several antigens. As the consistency and durability of the cellular response are important in this context, it is favorable to monitor kinetics of CTL responses from the same animal. This will also lead to a reduction of animal numbers, an important aspect regarding the principles of the "3Rs" 3 . Hence, analysis from as little as 20 µL of blood is optimal for this purpose.
Tetramers were developed in the late 90s 4 and became an important tool in the field of T cell immunology. Tetramers are fluorescently-labeled complexes of four MHC I/peptide molecules, which bind to TCRs, specific for a single peptide. Nowadays, they can be either bought readymade 5 , custom-ordered free of charge at the NIH Tetramer Core Facility at Emory University 6 or produced in the lab 7 . MHC I and II tetramers are available, i.e. for CD8 + and CD4 + T cells, respectively. The potency of tetramer staining lies in time-savings, rather simple and easy to standardize 8 2. Add 50 μL of tetramer dilution to each sample and vortex gently. Add FACS buffer only (without tetramer) to compensation controls and to the unstained sample. 3. Incubate samples for 20 min at 37 °C, protected from light. To ensure a seamless transition from tetramer to antibody staining, prepare the antibody mix as described in step 4 during the incubation time. NOTE: For each individual tetramer, optimal conditions (dilution, incubation time and temperature) need to be adjusted. Table 2 : Antibodies used in this protocol and optimal dilutions. Recommended surface markers (CD3, CD8, CD43, CD44 and CD62L) are listed in the first column. For each, the recommended fluorophore, optimized dilution and amount of antibody/sample are listed. In the last column, the cell type identified with each marker is specified. 
Preparation of Antibodies

Staining of Samples
1. Wash samples once by adding ~1 mL of FACS buffer and centrifuge for 5 min at 600 x g at 4-8 °C. After centrifugation, discard the supernatant and drain off remaining liquid on a stack of paper towels. NOTE: When working with blood, be cautious when draining off remaining liquid. Prior to the lysis of erythrocytes, blood will not stick to the bottom of the FACS tube. Alternatively, aspirate the supernatant. 2. Add 50 μL of the antibody mix to each cell pellet and vortex gently. 3. Add 50 μL of each compensation mix to the cell pellet of the corresponding compensation control and vortex gently.NOTE: ACK buffer will lead to osmotic swelling and lysis, specifically of erythrocytes. 2. Incubate for 5 min at room temperature in the dark. 3. Add 1 mL of FACS buffer and centrifuge for 5 min at 600 x g at 4-8 °C. After centrifugation, discard the supernatant and drain off the remaining liquid on a stack of paper towels. Note: When the pellet is rather red, repeat the lysis of erythrocytes. 4. Wash once by adding ~1-2 mL FACS buffer and centrifuge for 5 min at 600 x g at 4-8 °C. After centrifugation, discard the supernatant and drain off remaining liquid on a stack of paper towels. (Figure 2) . Representative blots for a negative control (naïve) mouse, as well as animals either vaccinated with either OVA-secreting Adenovirus 5 (Adeno-OVA) or OVA-expressing VSV-GP (VSV-GP-OVA) are shown. As seen in the lower blots two different tetramers can be combined in the same tube for staining. This allows simultaneous quantification of two different CTL specificities: virus-specific (VSV N) and transgene-specific (OVA) CTLs. We confirmed that single and double tetramer stainings give similar percentages of positive cells for each tetramer. Using this protocol, other virus-specific (e.g., LCMV GP, HPV 16 E7) or transgene-specific (e.g., GFP) T cell populations can be analyzed (Supplemental Figure 1) . In Supplemental Table 1 , results for five animals after immunization with VSV-GP-OVA are shown -indicating robustness of tetramer staining. One big advantage of the protocol described here is that T cell responses from the same mouse can be followed over time as only small amounts of blood are needed for each measurement. 
Flow Cytometric Measurement and Analysis
Discussion
Tetramer staining is a rather straightforward and uncomplicated protocol to analyze phenotype and peptide specificity of a T lymphocyte. The usage of blood for analysis, as described here, is minimally invasive and allows continuous monitoring, for example in vaccination studies. In the field of vaccination, the quantification of vector-and antigen-specific responses is of interest, as vector-specific responses might hinder an effective immune response against the vaccine antigen
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. Of note is that with the protocol described here, both populations can be quantified simultaneously in a single tetramer staining, thereby reducing staining variability and sample amounts. However, a few steps need to be done carefully to ensure proper measurement and reliable data. If using blood from the tail vein for analysis, one should make sure to pre-warm the animals to induce vasodilation 24 . Thereby, sufficient blood can be collected in a short time, stress on the animals is reduced and the analysis is much better, as compared to if the blood is collected slowly. Also, after sample collection (either blood or organs), direct staining is recommended to avoid false negative results due to TCR downregulation. The same applies for all subsequent steps: the procedure should not be interrupted and all washing steps reduced to the minimal number (as stated in the protocol). To ensure proper staining, care should be taken to vortex all solutions and samples prior to and after incubation. This is especially important before fixing the samples to avoid clumping of cells.
In terms of modifying the protocol, other surface markers and tetramers can be used, depending on the aim of the analysis. However, all reagents then need to be titrated, optimally in combination with the whole staining panel. For some of the tetramers specified here, optimization revealed that we can increase the dilution recommended by the manufacturer (1:10 recommended, optimized 1:25) ( Table 1) . To compensate spectral overlap, compensation beads can be used instead of stained cells. Regarding the choice of the tetramer-coupled fluorochrome, one should envisage to use bright fluorochromes, as this facilitates detection -especially when the signal is low. As Dolton and colleagues 29 , we prefer to use PE-or APC-coupled tetramers, which can be perfectly combined in a single staining and CD8 + T cells with a single antigen specificity can be nicely detected (Figure 2) . Regarding temperature and incubation times, a variety of tetramer staining conditions exist. In our optimization process, we addressed this issue and performed tetramer staining at different conditions (e.g. 4 °C, room temperature or 37 °C).
From the results obtained, we recommend to stain for 20 min at 37 °C, which is in concordance with literature 30, 31 . Prolonged incubation should be avoided, as this can lead to internalization of the tetramer 30 and false negative results.
The choice of the right antibody for detection of CD8 + cells is another important issue, which has to carefully considered (and potentially adapted). This arises from the fact that certain anti-CD8 antibody clones block binding of tetramers to the TCR, in human 32 as well as mouse 33 samples. For our tetramer staining protocol, we selected clone 53-6.7 to stain for murine CD8 + cells -a clone which does not block, but rather enhances tetramer staining.
Tetramer staining is rather uncomplicated when analyzing prominent immune responses at the peak of the T cell response, for example. However, there might be populations which are a bit more 'problematic'. Such examples include cells specific for low affinity antigens (tumor, self), recently activated cells which subsequently down-regulated their receptors or rare cell subsets (e.g. naïve precursor or memory cell populations). In these cases, the classical tetramer staining protocol might need to be improved or combined with other methods. For example, the protein kinase inhibitor (PKI) dasatinib inhibits TCR internalization and might be included prior to tetramer staining. Tetramers can also be stabilized by including anti-fluorochrome unconjugated primary Abs after tetramer staining. Additionally, fluorescence intensity can be increased by addition of a second anti-Ab fluorochrome-conjugated Ab 29, 34, 35, 36 . We optimized the conditions selectively for the tetramers specified in this protocol and did not include PKI or additional Abs. However, for any other tetramer, the optimal conditions have to be adjusted individually. With regard to rare populations, tetramer staining might need to be combined with magnetic enrichment 11 .
To facilitate and validate FACS analysis of tetramer staining, negative and positive controls should be included. As a negative control, we always stain cells of a naïve mouse of the same strain with our tetramer of interest. Alternatively, samples can be stained with tetramers with irrelevant peptides, but with the same fluorochrome as the tetramer of interest. Such controls are essential to exclude false positive signals, e.g., originating from dying cells. In addition to this, it is recommended to include a live/dead stain, such as propidium iodide (PI). This is of special importance if cells are not stained directly after isolation. Another strategy to remove autofluorescence background might be to include several non-T cell markers in one channel. By excluding cells positive in this channel, non-T cell populations can be excluded. As a positive control, a sample from an OT-1 mouse can be used for OVA tetramer, for example. For other tetramers, this has to be chosen individually (e.g., sample from a mouse, which was immunized several times). Alike others
The quality and amount of information one can retrieve from this protocol is dependent on the knowledge about the antigen to be studied, the availability and specificity of tetramer and the quality of the FACS machine (number of lasers and available detectors). If working with animal samples, variation in the immune response is natural and inevitable. Therefore, to gain meaningful results from tetramer staining, at least 3-5 animals should be analyzed. If done so, the protocol described here will give reliable and reproducible results (exemplary result from one experiment can be found in Supplemental Table 1 ). As mentioned before, this method is perfectly suited to quantify the phenotype and antigenspecificity of CD8 + T cells (Figure 3, 4; Supplemental Figure 1) , not only in the mouse but also in humans. However, to analyze CD8 + T cell effector functions, such as granzyme-induced cell death, ICS and/or ELISpot need to be performed. However, one should keep in mind that T cell functions, as measured by in vitro stimulation might not represent the actual situation in vivo. In vivo, a suppressive environment might prevent T cell functions which are measured in vitro.
On its own, tetramer staining does not provide all information, but it evolved to become an essential method to characterize T cell responses and quantify T cell subsets in vitro in a very sensitive manner 38 . Tetramers cannot only be used to quantify certain subsets, but also to isolate those 39 , localize them by in situ hybridization 19, 20 and study low-affinity antigens, such as tumor-associated 40, 41 . Since the discovery of tetramer technology 4 , tetramer staining has become an essential tool in T-cell analysis and the range of applications.
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